Skip to main content
Each stage of the pipeline asks different questions of different sources: human genetics and experiments for a target, trial registries and disclosures for clinical development, documentation for the lab systems behind it. These workflows keep study identifiers, evidence types and dates separate so every row can be checked.
Target discoveryTarget evidence mappingSeparate genetic associations, perturbation experiments and intervention evidence for a target.PCSK9 and LDL cholesterolClinical developmentClinical trial landscapeMap trial records to dated primary disclosures without implying cross-trial superiority.KRAS G12C NSCLC, CodeBreaK 200 and KRYSTAL-12Lab operationsResearch software evaluationCompare sample lineage, experiment records and fermentation-data integration across tools.openBIS and eLabFTW

​
See a finished report

GLP-1 drugs in Alzheimer's and Parkinson's disease

A Max-mode evidence review of GLP-1 drugs in Alzheimer’s and Parkinson’s disease, prioritising Wiley HLS and PubMed, with a CSV of 24 registered trials. Open the report, download the CSV or see the request.

​
Run a workflow

Each workflow page has a runnable request and notes on checking the output. Use Search when your application owns retrieval and analysis, or DeepResearch for a cited report and files. Check data sources for the evidence your task needs. See how biotech and pharma teams use Valyu on valyu.ai.